Xin Lang Cai Jing·2026-01-15 08:53Core Viewpoint - Rongchang Biotech announced a plan to repurchase shares between 20 million to 40 million yuan at a price not exceeding 95 yuan per share, intended for employee stock ownership plans or equity incentives, with the implementation still pending as of the announcement date [1] Group 1 - The company plans to hold a board meeting on January 15, 2026, to review a proposal to raise the repurchase price ceiling from 95 yuan per share to 116 yuan per share, while keeping other terms unchanged [1] - The adjustment to the repurchase price is due to the recent stock price consistently exceeding the previous upper limit [1] - There is a risk that the repurchase plan may not be implemented if the stock price exceeds the new upper limit during the repurchase period [1]